Suppr超能文献

儿科重症监护中的精神药理学

Psychopharmacology in pediatric critical care.

作者信息

Stoddard Frederick J, Usher Craigan T, Abrams Annah N

机构信息

Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.

出版信息

Child Adolesc Psychiatr Clin N Am. 2006 Jul;15(3):611-55. doi: 10.1016/j.chc.2006.02.005.

Abstract

Psychopharmacologic treatment in pediatric critical care requires a careful child or adolescent psychiatric evaluation, including a thorough review of the history of present illness or injury, any current or pre-existing psychiatric disorder, past history, and laboratory studies. Although there is limited evidence to guide psychopharmacologic practice in this setting, psychopharmacologic treatment is increasing in critical care, with known indications for treatment, benefits, and risks; initial dosing guidelines; and best practices. Treatment is guided by the knowledge bases in pediatric physiology, psycho-pharmacology, and treatment of critically ill adults. Pharmacologic considerations include pharmacokinetic and pharmcodynamic aspects of specific drugs and drug classes, in particular elimination half-life, developmental considerations, drug interactions, and adverse effects. Evaluation and management of pain is a key initial step, as pain may mimic psychiatric symptoms and its effective treatment can ameliorate them. Patient comfort and safety are primary objectives for children who are acutely ill and who will survive and for those who will not. Judicious use of psychopharmacolgic agents in pediatric critical care using the limited but growing evidence base and a clinical best practices collaborative approach can reduce anxiety,sadness, disorientation, and agitation; improve analgesia; and save lives of children who are suicidal or delirious. In addition to pain, other disorders or indications for psychopharmacologic treatment are affective disorders;PTSD; post-suicide attempt patients; disruptive behavior disorders (especially ADHD); and adjustment, developmental, and substance use disorders. Treating children who are critically ill with psychotropic drugs is an integral component of comprehensive pediatric critical care in relieving pain and delirium; reducing inattention or agitation or aggressive behavior;relieving acute stress, anxiety, or depression; and improving sleep and nutrition. In palliative care, psychopharmacology is integrated with psychologicapproaches to enhance children's comfort at the end of life. Defining how best to prevent the adverse consequences of suffering and stress in pediatric critical care is a goal for protocols and for new psychopharmacologic research [23,153].

摘要

儿科重症监护中的心理药物治疗需要对儿童或青少年进行仔细的精神科评估,包括全面回顾现患疾病或损伤史、任何当前或既往存在的精神障碍、既往史以及实验室检查。尽管在这种情况下指导心理药物治疗实践的证据有限,但心理药物治疗在重症监护中越来越普遍,有已知的治疗适应证、益处和风险;初始给药指南以及最佳实践。治疗以儿科生理学、心理药理学和重症成年患者治疗的知识库为指导。药理学考虑包括特定药物和药物类别的药代动力学和药效学方面,特别是消除半衰期、发育因素、药物相互作用和不良反应。疼痛的评估和管理是关键的初始步骤,因为疼痛可能模仿精神症状,其有效治疗可以改善这些症状。对于急性病且能存活的儿童以及无法存活的儿童,患者的舒适度和安全性是首要目标。利用有限但不断增加的证据基础以及临床最佳实践协作方法,在儿科重症监护中明智地使用心理药物可以减轻焦虑、悲伤、定向障碍和躁动;改善镇痛效果;挽救有自杀倾向或谵妄的儿童的生命。除疼痛外,心理药物治疗的其他疾病或适应证包括情感障碍;创伤后应激障碍;自杀未遂患者;破坏性行为障碍(尤其是注意力缺陷多动障碍);以及适应障碍、发育障碍和物质使用障碍。用精神药物治疗重症儿童是综合儿科重症监护的一个组成部分,可缓解疼痛和谵妄;减少注意力不集中、躁动或攻击性行为;缓解急性应激、焦虑或抑郁;并改善睡眠和营养。在姑息治疗中,心理药理学与心理方法相结合,以提高儿童临终时的舒适度。确定如何最好地预防儿科重症监护中痛苦和压力的不良后果是方案制定和新的心理药物研究的目标[23,153]。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验